OSI PHARMACEUTICALS, INC.

Inactive Instrument

OSI Pharmaceuticals, Inc. Share Price

Stocks

US6710401034

Biotechnology & Medical Research

End-of-day quote Nasdaq
- ^USD	-

Press Releases: OSI Pharmaceuticals, Inc.

09/06/10	OSI PHARM : Astellas Completes Acquisition of OSI Pharmaceuticals	PR
08/06/10	OSI PHARM : Astellas Announces Successful Completion of Tender Offer for Shares of OSI	PR
04/06/10	OSI PHARM : OSI Pharmaceuticals Announces Occurrence of a Fundamental Change for Convertible Notes	BU
03/06/10	OSI PHARM : Astellas Announces Successful Completion of Initial Tender Offer for Shares of OSI and Announces Subsequent Offer Period	PR
17/05/10	OSI PHARM : Expiration Date of OSI Offer Extended to June 2, 2010	PR

More press releases

News in other languages: OSI Pharmaceuticals, Inc.

17/05/10

OSI PHARM : a reçu une offre de rachat du japonais Astellas

Other Biotechnology & Medical Research

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
	LONZA GROUP AG	+1.51%	-3.85%	-1.50%	+10.16%	45.48B
	REVOLUTION MEDICINES, INC.	+0.21%	-2.98%	+337.74%	+520.30%	43.68B
	IQVIA HOLDINGS INC.	+1.74%	-2.24%	+39.82%	+20.85%	43.09B
	BEONE MEDICINES AG	+1.38%	-3.28%	+6.84%	+73.19%	39.4B
	CELLTRION, INC.	-1.44%	-5.26%	+8.97%	+39.76%	31.91B
	ASCENDIS PHARMA A/S	+0.87%	-2.60%	-	-	17.31B
	MEDPACE HOLDINGS, INC.	+0.75%	-0.64%	+19.75%	+108.58%	16.4B
	EUROFINS SCIENTIFIC SE	+2.80%	+1.51%	+15.22%	+31.86%	14.24B
	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+1.93%	-3.55%	+82.00%	+36.66%	13.28B
	Average	+1.08%	-3.20%	+63.61%	+105.17%	29.42B
	Weighted average by Cap.	+0.95%	-3.50%	+75.10%	+125.10%

See all sector performances

Company Profile

Employees

-

Sector

Biotechnology & Medical Research

More about the company

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!

SEIZE THE OFFER!